Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia
NCT00036088
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
530
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
Olanzapine
Sponsor
Eli Lilly and Company